PDX Model Market is expected to increase at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2035
The PDX model market is expected to increase at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2035, from its estimated USD 0.32 billion in 2025 to USD 1.17 billion by that time. Fresh human tumor tissue is directly transferred into immunocompromised mice in PDX models. This method preserves the main characteristics of the original tumor, including its cellular composition, three-dimensional shape, and the complex molecular landscape of the patient's specific cancer. Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/pdx-model-market GROWTH DRIVERS The worldwide movement toward precision medicine is the main factor propelling the market. In conventional oncology, "one-size-fits-all" blockbuster drugs usually don't work because tumors are inherently genetically varied. By serving as "patient avatars," PDX models allow doctors to evaluate different treatment strategies on a patient's tumor in vivo...